Related references
Note: Only part of the references are listed.Therapeutic Potential of Multifunctional Tacrine Analogues
Maja Przybylowska et al.
CURRENT NEUROPHARMACOLOGY (2019)
Association between brain amyloid accumulation and neuropsychological characteristics in elders with depression and mild cognitive impairment
HyunChul Youn et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2019)
Implications of sleep disturbance and inflammation for Alzheimer's disease dementia
Michael R. Irwin et al.
LANCET NEUROLOGY (2019)
Longitudinal Association of Depression Symptoms With Cognition and Cortical Amyloid Among Community-Dwelling Older Adults
Jennifer R. Gatchel et al.
JAMA NETWORK OPEN (2019)
Cerebrospinal Fluid Amyloid-β Levels are Increased in Patients with Insomnia
Dong-Wan Chen et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Impact of SSRI Therapy on Risk of Conversion From Mild Cognitive Impairment to Alzheimer's Dementia in Individuals With Previous Depression
Claudia Bartels et al.
AMERICAN JOURNAL OF PSYCHIATRY (2018)
Alzheimer's Disease, Oligomers, and Inflammation
Gianluigi Forloni et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Plasma Aβ analysis using magnetically-labeled immunoassays and PET 18F-florbetapir binding in non-demented patients with major depressive disorder
Kuan-Yi Wu et al.
SCIENTIFIC REPORTS (2018)
When Cognitive Decline and Depression Coexistin the Elderly: CSF Biomarkers Analysis Can Differentiate Alzheimer's Disease from Late-Life Depression
Claudio Liguori et al.
FRONTIERS IN AGING NEUROSCIENCE (2018)
Depression and Alzheimer's Disease Biomarkers Predict Driving Decline
Ganesh M. Babulal et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Plasma Amyloid-β and Alzheimer's Disease-Related Changes in Late-Life Depression
Chiemi Yamazaki et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Beta-amyloid deposition in patients with major depressive disorder with differing levels of treatment resistance: a pilot study
Peng Li et al.
EJNMMI RESEARCH (2017)
Adult hippocampal neurogenesis: Is it the alpha and omega of antidepressant action?
Hoda Eliwa et al.
BIOCHEMICAL PHARMACOLOGY (2017)
Oxidative stress, protein modification and Alzheimer disease
A. Tramutola et al.
BRAIN RESEARCH BULLETIN (2017)
Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies
C. A. Kohler et al.
ACTA PSYCHIATRICA SCANDINAVICA (2017)
No Association of Lower Hippocampal Volume With Alzheimer's Disease Pathology in Late-Life Depression
Francois-Laurent De Winter et al.
AMERICAN JOURNAL OF PSYCHIATRY (2017)
Effects of serotonin in the hippocampus: how SSRIs and multimodal antidepressants might regulate pyramidal cell function
Elena Dale et al.
CNS SPECTRUMS (2016)
Amyloid-associated depression and ApoE4 allele: longitudinal follow-up for the development of Alzheimer's disease
Wei Qiao Qiu et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2016)
Combined treatment with memantine/es-citalopram for older depressed patients with cognitive impairment: a pilot study
Gregory H. Pelton et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2016)
The contribution of neuroinflammation to amyloid toxicity in Alzheimer's disease
Myles R. Minter et al.
JOURNAL OF NEUROCHEMISTRY (2016)
Serum Levels of Albumin-β-Amyloid Complex in Patients with Depression
Megumi Inoue et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2016)
Neurovascular dysfunction and neurodegeneration in dementia and Alzheimer's disease
Amy R. Nelson et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2016)
Beta-amyloid deposition and cognitive function in patients with major depressive disorder with different subtypes of mild cognitive impairment: 18F-florbetapir (AV-45/Amyvid) PET study
Kuan-Yi Wu et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2016)
Electroconvulsive therapy selectively enhances amyloid β 1-42 in the cerebrospinal fluid of patients with major depression: A prospective pilot study
Laura Kranaster et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2016)
High amyloid-β deposition related to depressive symptoms in older individuals with normal cognition: a pilot study
Fumihiko Yasuno et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2016)
State-dependent alterations in cerebrospinal fluid A42 levels in cognitively intact elderly with late-life major depression
Nunzio Pomara et al.
NEUROREPORT (2016)
Citalopram, Methylphenidate, or Their Combination in Geriatric Depression: A Randomized, Double-Blind, Placebo-Controlled Trial
Helen Lavretsky et al.
AMERICAN JOURNAL OF PSYCHIATRY (2015)
Alzheimer's Disease Risk Genes and Mechanisms of Disease Pathogenesis
Celeste M. Karch et al.
BIOLOGICAL PSYCHIATRY (2015)
Speed of remission in elderly patients with depression: electroconvulsive therapy v. medication
Harm-Pieter Spaans et al.
BRITISH JOURNAL OF PSYCHIATRY (2015)
Major depression induces oxidative stress and platelet hyperaggregability
Monique B. O. Ormonde do Carmo et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2015)
Plasma biosignature and brain pathology related to persistent cognitive impairment in late-life depression
B. S. Diniz et al.
MOLECULAR PSYCHIATRY (2015)
Higher CSF interleukin-6 and CSF interleukin-8 in current depression in older women. Results from a population-based sample
Silke Kern et al.
BRAIN BEHAVIOR AND IMMUNITY (2014)
Modulatory Activity of Soluble Beta Amyloid on HPA Axis Function in Rats
Maria Grazia Morgese et al.
CURRENT PHARMACEUTICAL DESIGN (2014)
Increased brain amyloid deposition in patients with a lifetime history of major depression: evidenced on 18F-florbetapir (AV-45/Amyvid) positron emission tomography
Kuan-Yi Wu et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2014)
The Intersection of Amyloid Beta and Tau at Synapses in Alzheimer's Disease
Tara L. Spires-Jones et al.
NEURON (2014)
Current electroconvulsive therapy practice and research in the geriatric population
Nancy Kerner et al.
NEUROPSYCHIATRY (2014)
Effect of Anti-inflammatory Treatment on Depression, Depressive Symptoms, and Adverse Effects A Systematic Review and Meta-analysis of Randomized Clinical Trials
Ole Kohler et al.
JAMA PSYCHIATRY (2014)
Neurodegeneration, β-amyloid and mood disorders: state of the art and future perspectives
Armando Piccinni et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2013)
A review of lifestyle factors that contribute to important pathways associated with major depression: Diet, sleep and exercise
Adrian L. Lopresti et al.
JOURNAL OF AFFECTIVE DISORDERS (2013)
Plasma amyloid β, depression, and dementia in community-dwelling elderly
Nese Direk et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2013)
Plasma Beta Amyloid Level and Depression in Older Adults
Andrea L. Metti et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2013)
Depression and Incident Dementia. An 8-Year Population-Based Prospective Study
Melanie Luppa et al.
PLOS ONE (2013)
Heterogeneity of elderly depression: Increased risk of Alzheimer's disease and Aβ protein metabolism
Yuki Namekawa et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2013)
A Randomized Controlled Trial of the Tumor Necrosis Factor Antagonist Infliximab for Treatment-Resistant Depression
Charles L. Raison et al.
JAMA PSYCHIATRY (2013)
Lower CSF Amyloid Beta Peptides and Higher F2-lsoprostanes in Cognitively Intact Elderly Individuals With Major Depressive Disorder
Nunzio Pomara et al.
AMERICAN JOURNAL OF PSYCHIATRY (2012)
Midlife vs Late-Life Depressive Symptoms and Risk of Dementia
Kristine Yaffe
ARCHIVES OF GENERAL PSYCHIATRY (2012)
Cerebrospinal Fluid Levels of β-Amyloid 1-42, but Not of Tau, Are Fully Changed Already 5 to 10 Years Before the Onset of Alzheimer Dementia
Peder Buchhave et al.
ARCHIVES OF GENERAL PSYCHIATRY (2012)
Depressive Symptoms in Mild Cognitive Impairment Predict Greater Atrophy in Alzheimer's Disease-Related Regions
Grace J. Lee et al.
BIOLOGICAL PSYCHIATRY (2012)
Cerebrospinal Fluid Biomarkers in Alzheimer's Disease and Geriatric Depression: Preliminary Findings from Brazil
Taylor Reis et al.
CNS NEUROSCIENCE & THERAPEUTICS (2012)
Lowered Serum Amyloid-β1-42 Autoantibodies in Individuals with Lifetime Depression
Walter Maetzler et al.
JOURNAL OF ALZHEIMERS DISEASE (2012)
Metabolism of Amyloid-β Protein May Be Affected in Depression
Hajime Baba et al.
JOURNAL OF CLINICAL PSYCHIATRY (2012)
Plasma β-Amyloid Levels in Cerebral Amyloid Angiopathy-Associated Hemorrhagic Stroke
Mar Hernandez-Guillamon et al.
NEURODEGENERATIVE DISEASES (2012)
A review of Atypical depression in relation to the course of depression and changes in HPA axis organization
Veronica O'Keane et al.
PSYCHONEUROENDOCRINOLOGY (2012)
Depression and Cognitive Impairment in Older Adults
Sara L. Weisenbach et al.
CURRENT PSYCHIATRY REPORTS (2012)
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Reisa A. Sperling et al.
ALZHEIMERS & DEMENTIA (2011)
The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Marilyn S. Albert et al.
ALZHEIMERS & DEMENTIA (2011)
A Systematic Review of Treatments for Refractory Depression in Older People
Claudia Cooper et al.
AMERICAN JOURNAL OF PSYCHIATRY (2011)
Chemical characterization of pro-inflammatory amyloid-beta peptides in human atherosclerotic lesions and platelets
Tyler A. Kokjohn et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2011)
Antipsychotic medication is associated with selective alterations in ventricular cerebrospinal fluid Aβ 40 and tau in patients with intractable unipolar depression
Nicholas A. Clarke et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2011)
Efficacy of Antidepressants for Late-Life Depression: A Meta-Analysis and Meta-Regression of Placebo-Controlled Randomized Trials
Enrico Tedeschini et al.
JOURNAL OF CLINICAL PSYCHIATRY (2011)
Depression and risk of developing dementia
Amy L. Byers et al.
NATURE REVIEWS NEUROLOGY (2011)
The correlation of plasma Aβ42 levels, depressive symptoms, and cognitive function in the Korean elderly
Yoo Sun Moon et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2011)
Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease
Randall J. Bateman et al.
ALZHEIMERS RESEARCH & THERAPY (2011)
Plasma Amyloid Beta-42 Independently Predicts Both Late-Onset Depression and Alzheimer Disease
Imrich Blasko et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2010)
Structural conversion of neurotoxic amyloid-β1-42 oligomers to fibrils
Mahiuddin Ahmed et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2010)
Neurodegenerative basis of age-related cognitive decline
R. S. Wilson et al.
NEUROLOGY (2010)
Recurrent depressive symptoms and the incidence of dementia and mild cognitive impairment
Vonetta M. Dotson et al.
NEUROLOGY (2010)
Depressive symptoms and risk of dementia The Framingham Heart Study
J. S. Saczynski et al.
NEUROLOGY (2010)
Pramipexole for stage 2 treatment-resistant major depression: An open study
Takeshi Inoue et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2010)
Decreased Clearance of CNS β-Amyloid in Alzheimer's Disease
Kwasi G. Mawuenyega et al.
SCIENCE (2010)
Depression and Plasma Amyloid β Peptides in the Elderly With and Without the Apolipoprotein E4 Allele
Xiaoyan Sun et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2009)
Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer's disease
Alex E. Roher et al.
ALZHEIMERS & DEMENTIA (2009)
What is the association between depression and Alzheimer's disease?
Norifumi Tsuno et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2009)
Serum amyloid β protein in young and elderly depression: a pilot study
Yohei Kita et al.
PSYCHOGERIATRICS (2009)
Beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) as a biological candidate marker of Alzheimer's disease
Harald Hampel et al.
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (2009)
Amyloid-associated depression - A prodromal depression of Alzheimer disease?
Xiaoyan Sun et al.
ARCHIVES OF GENERAL PSYCHIATRY (2008)
Lithium Treatment and Risk of Dementia
Lars Vedel Kessing et al.
ARCHIVES OF GENERAL PSYCHIATRY (2008)
Treatment of vascular depression using repetitive transcranial magnetic stimulation
Ricardo E. Jorge et al.
ARCHIVES OF GENERAL PSYCHIATRY (2008)
Adherence to depression treatment in older adults - A narrative review
Kara Zivin et al.
DRUGS & AGING (2008)
Prevalence and risk factors for depression in non-demented primary care attenders aged 75 years and older
Siegfried Weyerer et al.
JOURNAL OF AFFECTIVE DISORDERS (2008)
Plaque-bearing mice with reduced levels of oligomeric amyloid-β assemblies have intact memory function
S. Lesne et al.
NEUROSCIENCE (2008)
HPA axis and sleep: Identifying subtypes of major depression
Irina Antonijevic
STRESS-THE INTERNATIONAL JOURNAL ON THE BIOLOGY OF STRESS (2008)
Depression, antidepressants, and plasma amyloid β (Beta) peptides in those elderly who do not have cardiovascular disease
Xiaoyan Sun et al.
BIOLOGICAL PSYCHIATRY (2007)
Distinguishing between depression and dementia in older persons: Neuropsychological and neuropathological correlates
Sara L. Wright et al.
JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY (2007)
Blood-based neurochemical diagnosis of vascular dementia: A pilot study
Mirko Bibl et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Depression is associated with low plasma Aβ42 independently of cardiovascular disease in the homebound elderly
Wei Qiao Qiu et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2007)
Depression and risk for Alzheimer disease - Systematic review, meta-analysis, and metaregression analysis
RL Ownby et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
Elevation in plasma abeta42 in geriatric depression: A pilot study
Nunzio Pomara et al.
NEUROCHEMICAL RESEARCH (2006)
Depressive symptoms, vascular disease, and mild cognitive impairment - Findings from the cardiovascular health study
DE Barnes et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Aβ42 in humans
AM Fagan et al.
ANNALS OF NEUROLOGY (2006)
Depressive symptoms and cognitive decline in late life - A prospective epidemiological study
M Ganguli et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
Plasma β-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy
ME Gurol et al.
NEUROLOGY (2006)
Clinical and neuroimaging correlates of mild cognitive impairment in a middle-aged community sample: The Personality and Total Health through Life 60+study
R Kumar et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2006)
Apolipoprotein (apo) E4 enhances amyloid β peptide production in cultured neuronal cells:: ApoE structure as a potential therapeutic target
SM Ye et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Reduced hippocampal volumes and memory loss in patients with early- and late-onset depression
I Hickie et al.
BRITISH JOURNAL OF PSYCHIATRY (2005)
Plasma amyloid β, apolipoprotein E, lacunar infarcts, and white matter lesions
EJ van Dijk et al.
ANNALS OF NEUROLOGY (2004)
BACE1 - The beta-secretase enzyme in Alzheimer's disease
R Vassar
JOURNAL OF MOLECULAR NEUROSCIENCE (2004)
Alzheimer's disease-affected brain:: Presence of oligomeric Aβ ligands (ADDLs) suggests a molecular basis for reversible memory loss
YS Gong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Neuropsychological performance in patients with depression is associated with clinical, etiological and genetic risk factors
SL Naismith et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY (2003)
Depression in Alzheimer's disease: Heterogeneity and related issues
HCB Lee et al.
BIOLOGICAL PSYCHIATRY (2003)
Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory
PR Turner et al.
PROGRESS IN NEUROBIOLOGY (2003)
Does increased platelet release of Aβ peptide contribute to brain abnormalities in individuals with depression?
N Pomara et al.
MEDICAL HYPOTHESES (2003)
CSF Aβ 42 levels correlate with amyloid-neuropathology in a population-based autopsy study
D Strozyk et al.
NEUROLOGY (2003)
Amyloid β-protein (Aβ) assembly:: Aβ40 and Aβ42 oligomerize through distinct pathways
G Bitan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Depressive symptoms and cognitive decline in elderly people -: Longitudinal study
S Paterniti et al.
BRITISH JOURNAL OF PSYCHIATRY (2002)
Imaging amyloid-β deposits in vivo
BJ Bacskai et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2002)
Depression in Alzheimer's disease: is there a temporal relationship between the onset of depression and the onset of dementia?
R Heun et al.
EUROPEAN PSYCHIATRY (2002)
Depressive symptoms, cognitive decline, and risk of AD in older persons
RS Wilson et al.
NEUROLOGY (2002)
Depression in Alzheimer's disease: Overview and treatment
CG Lyketsos et al.
BIOLOGICAL PSYCHIATRY (2002)
Phases of Aβ-deposition in the human brain and its relevance for the development of AD
DR Thal et al.
NEUROLOGY (2002)
History of depression as a risk factor for dementia: an updated review
AF Jorm
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2001)
Early and late onset depression in old age: different aetiologies, same phenomenology
H Brodaty et al.
JOURNAL OF AFFECTIVE DISORDERS (2001)
Depression in later life: three etiologically different subgroups
MD Van den Berg et al.
JOURNAL OF AFFECTIVE DISORDERS (2001)
On neurodegenerative diseases, models, and treatment strategies: Lessons learned and lessons forgotten a generation following the cholinergic hypothesis
RT Bartus
EXPERIMENTAL NEUROLOGY (2000)
Amyloid-β peptides interact with plasma proteins and erythrocytes:: Implications for their quantitation in plasma
YM Kuo et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
Share Paper
